Guido Filler
Guido Filler
Professor of Paediatrics, Western University, London, Ontario
Verified email at - Homepage
Cited by
Cited by
American heart association statistics committee and stroke statistics subcommittee
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Heart disease and stroke statistics-2017 update: a report from the Americaná…, 2017
Cystatin C as a marker of GFR—history, indications, and future research
G Filler, A B÷kenkamp, W Hofmann, T Le Bricon, C MartÝnez-Br˙, A Grubb
Clinical biochemistry 38 (1), 1-8, 2005
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome
A Richards, EJ Kemp, MK Liszewski, JA Goodship, AK Lampe, R Decorte, ...
Proceedings of the National Academy of Sciences 100 (22), 12966-12971, 2003
Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula?
G Filler, N Lepage
Pediatric nephrology 18 (10), 981-985, 2003
β-Trace Protein, Cystatin C, β2-Microglobulin, and Creatinine Compared for Detecting Impaired Glomerular Filtration Rates in Children
G Filler, F Priem, N Lepage, P Sinha, I Vollmer, H Clark, E Keely, ...
Clinical chemistry 48 (5), 729-736, 2002
Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C–based methods
C White, A Akbari, N Hussain, L Dinh, G Filler, N Lepage, GA Knoll
Journal of the American Society of Nephrology 16 (12), 3763-3770, 2005
Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation
R Trompeter, G Filler, NJA Webb, AR Watson, DV Milford, G Tyden, ...
Pediatric nephrology 17 (3), 141-149, 2002
Is there really an increase in non-minimal change nephrotic syndrome in children?
G Filler, E Young, P Geier, B Carpenter, A Drukker, J Feber
American journal of kidney diseases 42 (6), 1107-1113, 2003
Prevalence of complications in children with chronic kidney disease according to KDOQI
H Wong, K Mylrea, J Feber, A Drukker, G Filler
Kidney international 70 (3), 585-590, 2006
Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression
G Filler, M Zimmering, I Mai
Pediatric Nephrology 14 (2), 100-104, 2000
Rituximab in refractory nephrotic syndrome
A Prytuła, K Iijima, K Kamei, D Geary, E Gottlich, A Majeed, M Taylor, ...
Pediatric Nephrology 25 (3), 461-468, 2010
Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate
G Filler, F Priem, I Vollmer, J Gellermann, K Jung
Pediatric nephrology 13 (6), 501-505, 1999
Are Cystatin C and β2-Microglobulin Better Markers than Serum Creatinine for Prediction of a Normal Glomerular Filtration Rate in Pediatric Subjects?
G Filler, I Witt, F Priem, JHH Ehrich, K Jung
Clinical Chemistry 43 (6), 1077-1078, 1997
Limited sampling strategy for mycophenolic acid area under the curve
G Filler, I Mai
Therapeutic drug monitoring 22 (2), 169-173, 2000
Association between clinical risk factors and progression of chronic kidney disease in children
AO Staples, LA Greenbaum, JM Smith, DS Gipson, G Filler, BA Warady, ...
Clinical Journal of the American Society of Nephrology 5 (12), 2172-2179, 2010
One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience1
MT Millan, WE Berquist, SK So, MM Sarwal, KI Wayman, KL Cox, G Filler, ...
Transplantation 76 (10), 1458-1463, 2003
Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients
G Filler, I Neuschulz, I Vollmer, P Amendt, B Hocher
Nephrology Dialysis Transplantation 15 (6), 867-871, 2000
Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders
SD Marks, MP Massicotte, BT Steele, DG Matsell, G Filler, PS Shah, ...
The Journal of pediatrics 146 (6), 811-816, 2005
Four‐year data after pediatric renal transplantation: A randomized trial of tacrolimus vs. cyclosporin microemulsion
G Filler, NJA Webb, DV Milford, AR Watson, J Gellermann, G Tyden, ...
Pediatric transplantation 9 (4), 498-503, 2005
MDR1 haplotypes derived from exons 21 and 26 do not affect the steady‐state pharmacokinetics of tacrolimus in renal transplant patients
I Mai, ES Perloff, S Bauer, M Goldammer, A Johne, G Filler, K Budde, ...
British journal of clinical pharmacology 58 (5), 548-553, 2004
The system can't perform the operation now. Try again later.
Articles 1–20